Vitamin C and colds: prevention, duration and timing are separate questions
A Cochrane review found modest duration effects with regular supplementation but no consistent treatment effect after symptoms began.

Illustrative food image, not a photograph of the study intervention.
A supplement review, not a produce trial
This Cochrane review separated regular vitamin C supplementation from vitamin C started after cold symptoms appeared. It included placebo-controlled trials and excluded studies using less than 0.2 g per day. The authors searched major databases through 2012; this is a 2013 review, not a claim to incorporate every subsequent trial. Its outcomes included whether participants developed a cold, how long episodes lasted and how severe they were. These distinctions matter before any result is quoted. The experiments were about supplemental vitamin C, so a vegetable dish paired with this article should not be mistaken for an intervention tested by the review.
Hemilä H, Chalker E. The Cochrane database of systematic reviews, 2013. PMID 23440782 · DOI
Prevention depended on the population
Twenty-nine comparisons involving 11,306 participants contributed to the analysis of developing a cold during regular supplementation. In general-community trials involving 10,708 participants, the pooled risk ratio was 0.97, with a 95% confidence interval of 0.94 to 1.00. The authors concluded that regular supplementation did not reduce cold incidence in the general population. Five trials involving 598 marathon runners, skiers and soldiers on subarctic exercises gave a different estimate: a risk ratio of 0.48, with a confidence interval of 0.35 to 0.64. That specialized subgroup should not be silently substituted for the everyday community population when describing prevention.
Hemilä H, Chalker E. The Cochrane database of systematic reviews, 2013. PMID 23440782 · DOI
Duration was a different finding
Thirty-one comparisons covering 9,745 cold episodes examined duration during regular vitamin C use. Adult colds were shorter by 8%, with a reported interval of 3% to 12%; children's colds were shorter by 14%, with an interval of 7% to 21%. The review also reported reduced severity with regular administration. These findings concern illness duration and severity, not a demonstrated general-population prevention effect. A shorter episode and fewer people becoming ill are distinct outcomes. The percentages do not specify how many days every individual would save, and the article does not convert these pooled research findings into a personal supplement dose.
Hemilä H, Chalker E. The Cochrane database of systematic reviews, 2013. PMID 23440782 · DOI
Starting after symptoms did not reproduce the result
Seven comparisons involving 3,249 episodes examined therapeutic vitamin C, meaning use in the treatment setting rather than continuous regular supplementation. The review found no consistent effect on duration or severity in those trials. Thus, the regular-use duration finding cannot be repackaged as proof that starting vitamin C after symptoms reliably shortens a cold. Most included trials were randomized and double-blind; excluding trials lacking those features did not change the conclusions. The authors nevertheless called for further therapeutic randomized trials. The practical editorial boundary is simple: report timing, population and outcome together, without promising that food or supplements will prevent or treat an individual's cold.
Hemilä H, Chalker E. The Cochrane database of systematic reviews, 2013. PMID 23440782 · DOI